Laura Sepp-Lorenzino
Chief Scientific Officer
Analyst — CSO
Other
Board Member
Earnings-call appearances
-
Intellia Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-07
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-08
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-09
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q4 FY2023 Earnings Call2024-02-22
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-09
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-03
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q4 FY2022 Earnings Call2023-01-05
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-03
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-04
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-05
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q3 FY2021 Earnings Call2021-11-04
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q2 FY2021 Earnings Call2021-08-05
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-06
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q4 FY2020 Earnings Call2021-01-07
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q3 FY2020 Earnings Call2020-11-05
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q2 FY2020 Earnings Call2020-08-06
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q1 FY2020 Earnings Call2020-05-07
Intellia Therapeutics, Inc. (NTLA)